Skip to main content

Table 3 Number of events in each group

From: Survival benefit of induction chemotherapy for locally advanced nasopharyngeal carcinoma: prognosis based on a new risk estimation model

  IC + CCRT(n = 220) CCRT + AC (n = 170) IC + CCRT + AC(n = 339) P value
Failures 56 (25.5%) 44 (25.9%) 11 (33.0%) P = 0.225
Deaths 25 (11.4%) 22 (12.9%) 44 (13.0%) P = 0.992
Locoregional failure 21 (9.5%) 13 (7.6%) 36 (10.6%) P = 0.549
Distant failures 33 (15.0%) 33 (19.4%) 78 (23.0%) P = 0.174
  1. Data are n (%) or rate (95% CI). CCRT Concurrent chemoradiotherapy. P values were calculated with the log-rank test